Whole-Genome Analysis of Extensively Drug-Resistant Enterobacter hormaechei Isolated from a Patient with Non-Hodgkin's Lymphoma

Genes (Basel). 2024 Jun 20;15(6):814. doi: 10.3390/genes15060814.

Abstract

Background: Currently, the Enterobacteriaceae species are responsible for a variety of serious infections and are already considered a global public health problem, especially in underdeveloped countries, where surveillance and monitoring programs are still scarce and limited. Analyses were performed on the complete genome of an extensively antibiotic-resistant strain of Enterobater hormaechei, which was isolated from a patient with non-Hodgkin's lymphoma, who had been admitted to a hospital in the city of Manaus, Brazil.

Methods: Phenotypical identification and susceptibility tests were performed in automated equipment. Total DNA extraction was performed using the PureLink genomic DNA mini-Kit. The genomic DNA library was prepared with Illumina Microbial Amplicon Prep and sequenced in the MiSeq Illumina Platform. The assembly of the whole-genome and individual analyses of specific resistance genes extracted were carried out using online tools and the Geneious Prime software.

Results: The analyses identified an extensively resistant ST90 clone of E. hormaechei carrying different genes, including blaCTX-M-15, blaGES-2, blaTEM-1A, blaACT-15, blaOXA-1 and blaNDM-1, [aac(3)-IIa, aac(6')-Ian, ant(2″)-Ia], [aac(6')-Ib-cr, (qnrB1)], dfrA25, sul1 and sul2, catB3, fosA, and qnrB, in addition to resistance to chlorhexidine, which is widely used in patient antisepsis.

Conclusions: These findings highlight the need for actions to control and monitor these pathogens in the hospital environment.

Keywords: ampC; blood infections; efflux pump; mutations; plasmid; β-lactamases.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Brazil
  • Drug Resistance, Multiple, Bacterial* / genetics
  • Enterobacter* / drug effects
  • Enterobacter* / genetics
  • Enterobacter* / isolation & purification
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / genetics
  • Enterobacteriaceae Infections / microbiology
  • Genome, Bacterial*
  • Humans
  • Lymphoma, Non-Hodgkin* / drug therapy
  • Lymphoma, Non-Hodgkin* / genetics
  • Lymphoma, Non-Hodgkin* / microbiology
  • Microbial Sensitivity Tests
  • Whole Genome Sequencing* / methods

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Enterobacter hormaechei

Grants and funding

This research received no external funding. The funds to cover publication costs were provided by Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM)- POSGRAD 2023. Programa de Pós-graduação em Ciências Aplicadas à Hematologia—PPGH-UEA/HEMOAM, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.